NCT06097403

Brief Summary

Prevalance of cardiovascular complications in children with COVID 19 in Assuit university children hospital

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

October 22, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 24, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

October 24, 2023

Status Verified

October 1, 2023

Enrollment Period

11 months

First QC Date

October 22, 2023

Last Update Submit

October 22, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalance of cardiovascular complications in children with COVID 19

    estimate the prevalence of cardiovascular complications among pediatric patients with covid 19 in Isolation Unit , Chest unit , and Cardiology unit in Assiut University Children Hospital

    Baseline

Interventions

Covid 19 swapDIAGNOSTIC_TEST

diagnostic tool

Eligibility Criteria

Age1 Day - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All patients with covid 19 confirmed with PCR from January 2023 till 31 december 2023

You may qualify if:

  • Patient less than 18 years old Presented with COVID 19

You may not qualify if:

  • Not presented with covid19

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Das BB, Akam-Venkata J, Abdulkarim M, Hussain T. Parametric Mapping Cardiac Magnetic Resonance Imaging for the Diagnosis of Myocarditis in Children in the Era of COVID-19 and MIS-C. Children (Basel). 2022 Jul 16;9(7):1061. doi: 10.3390/children9071061.

    PMID: 35884045BACKGROUND

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

October 22, 2023

First Posted

October 24, 2023

Study Start

October 1, 2023

Primary Completion

September 1, 2024

Study Completion

October 1, 2024

Last Updated

October 24, 2023

Record last verified: 2023-10